Table 3.
Laboratory data and electrocardiogram findings at time of troponin elevation.
| All patients | Troponin | P value | |||
|---|---|---|---|---|---|
| Negative | Intermediate | Elevated | |||
| Avg. troponin (ng/mL) | 0.07 | 0.01 | 0.047 | 0.455 | P < 0.001 |
| MELD score | 11.20 | 8.89 | 13.10 | 14.0 | P = 0.003 |
| INR | 1.62 | 1.46 | 1.79 | 1.84 | P = 0.011 |
| Tbili (mg/dL) | 4.18 | 4.16 | 4.18 | 3.75 | P = 0.052 |
| Cr (mg/dL) | 1.14 | 0.095 | 1.25 | 1.73 | P = 0.093 |
| Renal dysfunction | 28 (35.9%) | 9 (21.4%) | 13 (46.4%) | 6 (75.0%) | P = 0.079 |
| ECG changes | |||||
| None | 40 (51.3%) | 25 (59.5%) | 14 (50.0%) | 1 (12.5%) | |
| ST elevation | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| ST depression | 2 (2.6%) | 0 (0.0%) | 2 (7.1%) | 0 (0.0%) | |
| Afib/flutter | 8 (10.3%) | 6 (14.3%) | 1 (3.6%) | 1 (12.5%) | |
| Nonspecific ST | 17 (21.8%) | 6 (14.3%) | 7 (25.0%) | 4 (50.0%) | |
| Sinus tachycardia | 8 (10.3%) | 4 (9.5%) | 4 (14.3%) | 0 (0.0%) | |
| New RBBB | 2 (2.6%) | 1 (2.4%) | 0 (0.0%) | 1 (12.5%) | |
| New LBBB | 1 (1.3%) | 0 (0.0%) | 0 (0.0%) | 1 (12.5%) | |
MELD: model for endstage liver disease; INR: international normalized ratio; Tbili: total bilirubin; Cr: creatinine; ECG: electrocardiogram; Afib/flutter: atrial fibrillation/flutter; Nonspecific ST: nonspecific ST changes; RBBB: right bundle branch block; LBBB: left bundle branch block.